Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.

Knaapila J, Jambor I, Perez IM, Ettala O, Taimen P, Verho J, Kiviniemi A, Pahikkala T, Merisaari H, Lamminen T, Saunavaara J, Aronen HJ, Syvänen KT, Boström PJ.

Eur Urol Oncol. 2019 Sep 6. pii: S2588-9311(19)30134-8. doi: 10.1016/j.euo.2019.08.008. [Epub ahead of print]

PMID:
31501082
2.

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.

Toivonen J, Montoya Perez I, Movahedi P, Merisaari H, Pesola M, Taimen P, Boström PJ, Pohjankukka J, Kiviniemi A, Pahikkala T, Aronen HJ, Jambor I.

PLoS One. 2019 Jul 8;14(7):e0217702. doi: 10.1371/journal.pone.0217702. eCollection 2019.

3.

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.

Jambor I, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ.

PLoS Med. 2019 Jun 3;16(6):e1002813. doi: 10.1371/journal.pmed.1002813. eCollection 2019 Jun.

4.

IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.

Merisaari H, Jambor I, Ettala O, Boström PJ, Montoya Perez I, Verho J, Kiviniemi A, Syvänen K, Kähkönen E, Eklund L, Pahikkala T, Vainio P, Saunavaara J, Aronen HJ, Taimen P.

J Magn Reson Imaging. 2019 Mar 22. doi: 10.1002/jmri.26727. [Epub ahead of print]

PMID:
30903647
5.

Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).

Jambor I, Kuisma A, Kähkönen E, Kemppainen J, Merisaari H, Eskola O, Teuho J, Perez IM, Pesola M, Aronen HJ, Boström PJ, Taimen P, Minn H.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):355-364. doi: 10.1007/s00259-017-3875-1. Epub 2017 Nov 16.

PMID:
29147764
6.

Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial).

Jambor I, Boström PJ, Taimen P, Syvänen K, Kähkönen E, Kallajoki M, Perez IM, Kauko T, Matomäki J, Ettala O, Merisaari H, Kiviniemi A, Dean PB, Aronen HJ.

J Magn Reson Imaging. 2017 Oct;46(4):1089-1095. doi: 10.1002/jmri.25641. Epub 2017 Feb 6.

PMID:
28165653
7.

Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A.

J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19.

8.

Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.

Ginsburg SB, Taimen P, Merisaari H, Vainio P, Boström PJ, Aronen HJ, Jambor I, Madabhushi A.

J Magn Reson Imaging. 2016 Dec;44(6):1405-1414. doi: 10.1002/jmri.25330. Epub 2016 Jun 10.

9.

Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction.

Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Kiviniemi A, Aronen HJ, Jambor I.

Magn Reson Med. 2017 Mar;77(3):1249-1264. doi: 10.1002/mrm.26169. Epub 2016 Feb 28.

PMID:
26924552
10.

Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization.

Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I.

Magn Reson Imaging. 2015 Dec;33(10):1212-1218. doi: 10.1016/j.mri.2015.07.004. Epub 2015 Jul 26.

PMID:
26220861
11.

Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness.

Jambor I, Pesola M, Merisaari H, Taimen P, Boström PJ, Liimatainen T, Aronen HJ.

Magn Reson Med. 2016 May;75(5):2130-40. doi: 10.1002/mrm.25808. Epub 2015 Jun 22.

PMID:
26094849
12.

Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.

Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari H, Saunavaara J, Noponen T, Minn H, Aronen HJ, Seppänen M.

Acta Oncol. 2016;55(1):59-67. doi: 10.3109/0284186X.2015.1027411. Epub 2015 Apr 2.

PMID:
25833330
13.

Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.

Jambor I, Pesola M, Taimen P, Merisaari H, Boström PJ, Minn H, Liimatainen T, Aronen HJ.

Magn Reson Med. 2016 Jan;75(1):337-44. doi: 10.1002/mrm.25647. Epub 2015 Mar 2.

PMID:
25733132
14.

Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm(2) : correlation with Gleason score and repeatability of region of interest analysis.

Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I.

Magn Reson Med. 2015 Oct;74(4):1116-24. doi: 10.1002/mrm.25482. Epub 2014 Oct 20.

PMID:
25329932
15.

Evaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate cancer using high b-values: a repeatability study.

Jambor I, Merisaari H, Taimen P, Boström P, Minn H, Pesola M, Aronen HJ.

Magn Reson Med. 2015 May;73(5):1988-98. doi: 10.1002/mrm.25323. Epub 2014 Jul 12.

PMID:
25046482
16.

Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.

Jambor I, Kähkönen E, Taimen P, Merisaari H, Saunavaara J, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ.

J Magn Reson Imaging. 2015 May;41(5):1394-404. doi: 10.1002/jmri.24682. Epub 2014 Jun 23.

PMID:
24956412
17.

Optimization of b-value distribution for biexponential diffusion-weighted MR imaging of normal prostate.

Jambor I, Merisaari H, Aronen HJ, Järvinen J, Saunavaara J, Kauko T, Borra R, Pesola M.

J Magn Reson Imaging. 2014 May;39(5):1213-22. doi: 10.1002/jmri.24271. Epub 2013 Oct 11.

PMID:
24127398
18.

Cavum septum pellucidum and psychopathy.

Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Seppänen A, Aronen HJ, Vanninen R, Tiihonen J, Laakso MP.

Br J Psychiatry. 2013 Aug;203(2):152-3. doi: 10.1192/bjp.bp.112.123844.

PMID:
23908342
19.

Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle.

Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB.

Int J Law Psychiatry. 2013 Mar-Apr;36(2):157-67. doi: 10.1016/j.ijlp.2013.01.008. Epub 2013 Feb 8.

20.

Progress in improving radiology residency training in Finland.

Aronen HJ, Dean PB.

J Am Coll Radiol. 2012 Apr;9(4):288-9. doi: 10.1016/j.jacr.2011.11.012. No abstract available.

PMID:
22469383
21.

Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.

Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H.

Eur J Radiol. 2012 Nov;81(11):2966-72. doi: 10.1016/j.ejrad.2011.12.043. Epub 2012 Feb 18.

PMID:
22342610
22.

Cortex and amygdala morphology in psychopathy.

Boccardi M, Frisoni GB, Hare RD, Cavedo E, Najt P, Pievani M, Rasser PE, Laakso MP, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J.

Psychiatry Res. 2011 Aug 30;193(2):85-92. doi: 10.1016/j.pscychresns.2010.12.013. Epub 2011 Jun 15.

PMID:
21676597
23.

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinistö L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN.

Neurology. 2010 Dec 7;75(23):2071-8. doi: 10.1212/WNL.0b013e318200d6f9. Epub 2010 Nov 3.

24.

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.

Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H.

J Nucl Med. 2010 Nov;51(11):1676-83. doi: 10.2967/jnumed.110.078667. Epub 2010 Oct 18.

25.

Abnormal hippocampal shape in offenders with psychopathy.

Boccardi M, Ganzola R, Rossi R, Sabattoli F, Laakso MP, Repo-Tiihonen E, Vaurio O, Könönen M, Aronen HJ, Thompson PM, Frisoni GB, Tiihonen J.

Hum Brain Mapp. 2010 Mar;31(3):438-47. doi: 10.1002/hbm.20877.

PMID:
19718651
26.

Perfusion differences on SPECT and PWI in patients with acute ischemic stroke.

Nuutinen J, Liu Y, Laakso MP, Karonen JO, Vanninen EJ, Kuikka JT, Aronen HJ, Vanninen RL.

Neuroradiology. 2009 Oct;51(10):687-95. doi: 10.1007/s00234-009-0569-9. Epub 2009 Jul 22.

PMID:
19626319
27.

Brain anatomy of persistent violent offenders: more rather than less.

Tiihonen J, Rossi R, Laakso MP, Hodgins S, Testa C, Perez J, Repo-Tiihonen E, Vaurio O, Soininen H, Aronen HJ, Könönen M, Thompson PM, Frisoni GB.

Psychiatry Res. 2008 Aug 30;163(3):201-12. doi: 10.1016/j.pscychresns.2007.08.012. Epub 2008 Jul 26.

PMID:
18662866
28.

Brain activation and deactivation during location and color working memory tasks in 11-13-year-old children.

Vuontela V, Steenari MR, Aronen ET, Korvenoja A, Aronen HJ, Carlson S.

Brain Cogn. 2009 Feb;69(1):56-64. doi: 10.1016/j.bandc.2008.05.010. Epub 2008 Jul 11.

PMID:
18620789
29.

Physiological noise in MR images: an indicator of the tissue response to ischemia?

Wang HH, Menezes NM, Zhu MW, Ay H, Koroshetz WJ, Aronen HJ, Karonen JO, Liu Y, Nuutinen J, Wald LL, Sorensen AG.

J Magn Reson Imaging. 2008 Apr;27(4):866-71. doi: 10.1002/jmri.21007.

PMID:
18383248
30.

The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.

Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T.

Neurology. 2007 Oct 9;69(15):1521-7.

PMID:
17923614
31.

Diffusion and perfusion-weighted magnetic resonance imaging techniques in stroke recovery.

Aronen HJ, Laakso MP, Moser M, Perkiö J.

Eura Medicophys. 2007 Jun;43(2):271-84. Review.

32.

Violent persons with schizophrenia and comorbid disorders: a functional magnetic resonance imaging study.

Joyal CC, Putkonen A, Mancini-Marïe A, Hodgins S, Kononen M, Boulay L, Pihlajamaki M, Soininen H, Stip E, Tiihonen J, Aronen HJ.

Schizophr Res. 2007 Mar;91(1-3):97-102. Epub 2007 Feb 7.

PMID:
17291724
33.

The real estate factor: quantifying the impact of infarct location on stroke severity.

Menezes NM, Ay H, Wang Zhu M, Lopez CJ, Singhal AB, Karonen JO, Aronen HJ, Liu Y, Nuutinen J, Koroshetz WJ, Sorensen AG.

Stroke. 2007 Jan;38(1):194-7. Epub 2006 Nov 22.

PMID:
17122428
34.

ApoE polymorphism and acute stroke: a study with diffusion- and perfusion-weighted MRI and MR angiography.

Liu Y, Nuutinen J, Laakso MP, Karonen JO, Soimakallio S, Aronen HJ, Vanninen RL.

Acta Neurol Scand. 2006 Nov;114(5):323-8.

PMID:
17022780
36.

Sensorimotor cortex localization: comparison of magnetoencephalography, functional MR imaging, and intraoperative cortical mapping.

Korvenoja A, Kirveskari E, Aronen HJ, Avikainen S, Brander A, Huttunen J, Ilmoniemi RJ, Jääskeläinen JE, Kovala T, Mäkelä JP, Salli E, Seppä M.

Radiology. 2006 Oct;241(1):213-22. Epub 2006 Aug 14.

PMID:
16908676
37.

A cluster mass permutation test with contextual enhancement for fMRI activation detection.

Tillikainen L, Salli E, Korvenoja A, Aronen HJ.

Neuroimage. 2006 Aug 15;32(2):654-64.

PMID:
16769226
38.

Acute opioid effects on human brain as revealed by functional magnetic resonance imaging.

Leppä M, Korvenoja A, Carlson S, Timonen P, Martinkauppi S, Ahonen J, Rosenberg PH, Aronen HJ, Kalso E.

Neuroimage. 2006 Jun;31(2):661-9. Epub 2006 Feb 3.

PMID:
16459107
39.

Assessing the outcome of stroke: a comparison between MRI and clinical stroke scales.

Nuutinen J, Liu Y, Laakso MP, Karonen JO, Roivainen R, Vanninen RL, Partanen K, Østergaard L, Sivenius J, Aronen HJ.

Acta Neurol Scand. 2006 Feb;113(2):100-7.

PMID:
16411970
40.

Distinct and overlapping fMRI activation networks for processing of novel identities and locations of objects.

Pihlajamäki M, Tanila H, Könönen M, Hänninen T, Aronen HJ, Soininen H.

Eur J Neurosci. 2005 Oct;22(8):2095-105.

PMID:
16262647
41.

Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.

Sipola P, Lauerma K, Jääskeläinen P, Laakso M, Peuhkurinen K, Manninen H, Aronen HJ, Kuusisto J.

Radiology. 2005 Sep;236(3):815-24. Epub 2005 Jul 12.

PMID:
16014439
42.

Cortical generators of slow evoked responses elicited by spatial and nonspatial auditory working memory tasks.

Anurova I, Artchakov D, Korvenoja A, Ilmoniemi RJ, Aronen HJ, Carlson S.

Clin Neurophysiol. 2005 Jul;116(7):1644-54.

PMID:
15897006
43.

Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging.

Perkiö J, Soinne L, Østergaard L, Helenius J, Kangasmäki A, Martinkauppi S, Salonen O, Savolainen S, Kaste M, Tatlisumak T, Aronen HJ.

Stroke. 2005 Jan;36(1):44-9. Epub 2004 Dec 2.

PMID:
15576655
44.

Correlation of FDG-PET interpretation with survival in a cohort of glioma patients.

Pardo FS, Aronen HJ, Fitzek M, Kennedy DN, Efird J, Rosen BR, Fischman AJ.

Anticancer Res. 2004 Jul-Aug;24(4):2359-65.

45.

MRI volumetry of the vermis and the cerebellar hemispheres in men with schizophrenia.

Joyal CC, Pennanen C, Tiihonen E, Laakso MP, Tiihonen J, Aronen HJ.

Psychiatry Res. 2004 Jul 30;131(2):115-24.

PMID:
15313518
46.

Poststroke depression and lesion location revisited.

Vataja R, Leppävuori A, Pohjasvaara T, Mäntylä R, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T.

J Neuropsychiatry Clin Neurosci. 2004 Spring;16(2):156-62.

PMID:
15260366
47.

Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans.

Pihlajamäki M, Tanila H, Könönen M, Hänninen T, Hämäläinen A, Soininen H, Aronen HJ.

Eur J Neurosci. 2004 Apr;19(7):1939-49.

PMID:
15078568
48.

Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography--serial study with combined diffusion and perfusion MR imaging.

Liu Y, Karonen JO, Vanninen RL, Nuutinen J, Koskela A, Soimakallio S, Aronen HJ.

Radiology. 2004 May;231(2):517-27. Epub 2004 Mar 24.

PMID:
15044743
49.

EEG minimum-norm estimation compared with MEG dipole fitting in the localization of somatosensory sources at S1.

Komssi S, Huttunen J, Aronen HJ, Ilmoniemi RJ.

Clin Neurophysiol. 2004 Mar;115(3):534-42.

PMID:
15036048
50.

Visual processing of coherent rotation in the central visual field: an fMRI study.

Könönen M, Pääkkönen A, Pihlajamäki M, Partanen K, Karjalainen PA, Soimakallio S, Aronen HJ.

Perception. 2003;32(10):1247-57.

PMID:
14700259

Supplemental Content

Loading ...
Support Center